1. EMA agenda released for public hearing re: quinolones, FQs

   News item 23 June 2018 Pages: 1 - 1

2. Health Canada: no risk of tendon disorders with imatinib

   News item 23 June 2018 Pages: 2 - 2

3. Warnings of BLINCYTO + benzyl alcohol use in paediatrics

   News item 23 June 2018 Pages: 3 - 3

4. Adverse pregnancy outcomes with continued antiretrovirals

   Clinical study 23 June 2018 Pages: 4 - 4

5. Dengue-seronegative vaccine recipients at greatest risk

   Clinical study 23 June 2018 Pages: 5 - 5

6. Japanese encephalitis vaccine has favourable safety profile

   Clinical study 23 June 2018 Pages: 6 - 6

7. Medicines associated with depression commonly used in US

   Clinical study 23 June 2018 Pages: 7 - 7

8. Offspring outcomes following paternal antidepressant use

   Clinical study 23 June 2018 Pages: 8 - 8

9. Potential safety signals with biologic use identified

   Clinical study 23 June 2018 Pages: 9 - 9

10. Risk of lactic acidosis with metformin

    Clinical study 23 June 2018 Pages: 10 - 10

11. US reports of acute kidney injury with various drugs

    Clinical study 23 June 2018 Pages: 11 - 11

12. Acenocoumarol

    Case report 23 June 2018 Pages: 12 - 12

13. Acenocoumarol

    Case report 23 June 2018 Pages: 13 - 13

14. Adalimumab

    Case report 23 June 2018 Pages: 14 - 14

15. Adalimumab

    Case report 23 June 2018 Pages: 15 - 15

16. Adalimumab

    Case report 23 June 2018 Pages: 16 - 16

17. Adalimumab

    Case report 23 June 2018 Pages: 17 - 17

18. Adalimumab

    Case report 23 June 2018 Pages: 18 - 18

19. Adalimumab/infliximab

    Case report 23 June 2018 Pages: 19 - 19

20. Adalimumab/methotrexate

    Case report 23 June 2018 Pages: 20 - 20

21. Afatinib/osimertinib

    Case report 23 June 2018 Pages: 21 - 21

22. Albendazole

    Case report 23 June 2018 Pages: 22 - 22

23. Alectinib/crizotinib

    Case report 23 June 2018 Pages: 23 - 23

24. Alemtuzumab

    Case report 23 June 2018 Pages: 24 - 24

25. Alemtuzumab

    Case report 23 June 2018 Pages: 25 - 25

26. Alendronic acid

    Case report 23 June 2018 Pages: 26 - 26

27. Alendronic acid/minodronic acid/risedronic acid

    Case report 23 June 2018 Pages: 27 - 27

28. Amantadine

    Case report 23 June 2018 Pages: 28 - 28

29. Amiodarone

    Case report 23 June 2018 Pages: 29 - 29

30. Amiodarone/flecainide

    Case report 23 June 2018 Pages: 30 - 30

31. Amlodipine/calcium gluconate

    Case report 23 June 2018 Pages: 31 - 31

32. Amoxicillin/clarithromycin

    Case report 23 June 2018 Pages: 32 - 32

33. Anagrelide

    Case report 23 June 2018 Pages: 33 - 33

34. Anti-TNF-monoclonal-antibodies/cortisone

    Case report 23 June 2018 Pages: 34 - 34

35. Antimigraines and Antidepressants

    Case report 23 June 2018 Pages: 35 - 35

36. Antineoplastics

    Case report 23 June 2018 Pages: 36 - 36

37. Antineoplastics

    Case report 23 June 2018 Pages: 37 - 37

38. Antineoplastics

    Case report 23 June 2018 Pages: 38 - 38

39. Antineoplastics

    Case report 23 June 2018 Pages: 39 - 39

40. Antineoplastics

    Case report 23 June 2018 Pages: 40 - 40

41. Antineoplastics

    Case report 23 June 2018 Pages: 41 - 41

42. Antineoplastics

    Case report 23 June 2018 Pages: 42 - 42

43. Antineoplastics

    Case report 23 June 2018 Pages: 43 - 43

44. Antineoplastics

    Case report 23 June 2018 Pages: 44 - 44

45. Antineoplastics

    Case report 23 June 2018 Pages: 45 - 45

46. Antineoplastics/dexamethasone

    Case report 23 June 2018 Pages: 46 - 46

47. Antipsychotics

    Case report 23 June 2018 Pages: 47 - 47

48. Antipsychotics/unspecified prodopaminergic therapy

    Case report 23 June 2018 Pages: 48 - 48

49. Arginine/clonidine/glucagon

    Case report 23 June 2018 Pages: 49 - 49

50. Aripiprazole

    Case report 23 June 2018 Pages: 50 - 50